As filed with the Securities and Exchange Commission on February 27, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
PROCEPT BioRobotics Corporation
(Exact name of Registrant as specified in its charter)
| Delaware | 26-0199180 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | |||||||
150 Baytech Drive, San Jose, California | 95134 | |||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
2021 Equity Incentive Award Plan
2021 Employee Stock Purchase Plan
(Full Title of the Plan)
Reza Zadno, Ph.D.
Chief Executive Officer
150 Baytech Drive
San Jose, California 95134
(650) 232-7200
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Alaleh Nouri Chief Legal Officer Jonathan Stone Associate General Counsel 150 Baytechd Drive San Jose, California 95134 (650) 232-7200 | B. Shayne Kennedy Drew Capurro Latham & Watkins LLP 650 Town Center Drive, 20th Floor Costa Mesa, California 92626 (714) 540-1235 | ||||
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ | ||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed with the Securities and Exchange Commission for the purpose of registering an additional 3,282,387 shares of common stock, par value $0.00001 per share, of PROCEPT BioRobotics Corporation (the “Registrant”), issuable under the following employee benefit plans for which registration statements on Form S-8 (File Nos. 333-259586, 333-264758, 333-270113 and 333-277461) are effective: (i) the 2021 Equity Incentive Award Plan which, as a result of an automatic annual increase provision therein, added 2,735,323 shares of common stock, and (ii) the 2021 Employee Stock Purchase Plan which, as a result of the operation of an annual increase provision therein, added 547,064 shares of common stock.
Pursuant to General Instruction E to Form S-8, the contents of the above-referenced prior registration statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.
Item 8. Exhibits.
Exhibit Number | Exhibit Description | Form | Incorporated by Reference Date | Number | Filed Herewith | |||||||||||||||||||||||||||
| 4.1 | 8-K | 09/21/21 | 3.1 | |||||||||||||||||||||||||||||
| 4.2 | 8-K | 09/21/21 | 3.2 | |||||||||||||||||||||||||||||
| 5.1 | X | |||||||||||||||||||||||||||||||
| 23.1 | X | |||||||||||||||||||||||||||||||
| 23.2 | X | |||||||||||||||||||||||||||||||
| 24.1 | X | |||||||||||||||||||||||||||||||
| 99.1 | S-1/A | 09/08/21 | 10.11 | |||||||||||||||||||||||||||||
| 99.1(a) | S-1/A | 09/08/21 | 10.11(a) | |||||||||||||||||||||||||||||
| 99.1(b) | S-1/A | 09/08/21 | 10.11(b) | |||||||||||||||||||||||||||||
99.1(c) | 10-Q | 05/02/24 | 10.2 | |||||||||||||||||||||||||||||
| 99.2 | S-1/A | 09/08/21 | 10.12 | |||||||||||||||||||||||||||||
| 107 | X | |||||||||||||||||||||||||||||||
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Jose, State of California, on this 27th day of February, 2025.
| PROCEPT BioRobotics Corporation | |||||
| By: | /s/ Reza Zadno | ||||
| Reza Zadno, Ph.D. | |||||
| Chief Executive Officer | |||||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Reza Zadno and Kevin Waters, and each of them, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.
| Signature | Title | Date | ||||||||||||
| /s/ Reza Zadno | President, Director and Chief Executive Officer | February 27, 2025 | ||||||||||||
| Reza Zadno, Ph.D. | (Principal Executive Officer) | |||||||||||||
| /s/ Kevin Waters | EVP, Chief Financial Officer | February 27, 2025 | ||||||||||||
| Kevin Waters | (Principal Financial and Accounting Officer) | |||||||||||||
/s/ Thomas M. Prescott | Director and Chair of the Board | February 27, 2025 | ||||||||||||
Thomas M. Prescott | ||||||||||||||
| /s/ Antal Desai | Director | February 27, 2025 | ||||||||||||
| Antal Desai | ||||||||||||||
| /s/ Amy Dodrill | Director | February 27, 2025 | ||||||||||||
| Amy Dodrill | ||||||||||||||
/s/ Mary Garrett | Director | February 27, 2025 | ||||||||||||
Mary Garrett | ||||||||||||||
| /s/ Taylor Harris | Director | February 27, 2025 | ||||||||||||
| Taylor Harris | ||||||||||||||
/s/ Elisabeth Little | Director | February 27, 2025 | ||||||||||||
Elisabeth Little | ||||||||||||||
/s/ Frederic Moll, M.D. | Director | February 27, 2025 | ||||||||||||
Frederic Moll, M.D. | ||||||||||||||
/s/ Larry Wood | Director | February 27, 2025 | ||||||||||||
Larry Wood | ||||||||||||||